Citation: Ma Jing, Zhang Jingpeng, Chi Lin, Liu Chong, Li Yanhui, Tian Huayu. Preparation of poly(glutamic acid) shielding micelles self-assembled from polylysine-b-polyphenylalanine for gene and drug codelivery[J]. Chinese Chemical Letters, ;2020, 31(6): 1427-1431. doi: 10.1016/j.cclet.2020.02.034 shu

Preparation of poly(glutamic acid) shielding micelles self-assembled from polylysine-b-polyphenylalanine for gene and drug codelivery

Ma Jing ^a,b ,
Zhang Jingpeng ^a,b ,
Chi Lin ^a ,
Liu Chong ^a,b ,
Li Yanhui ^a,*, ,
Tian Huayu ^b,*,

a.
School of Materials Science and Engineering, Changchun University of Science and Technology, Changchun 130022, China
b.
Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China

lyh2008@cust.edu.cn

thy@ciac.ac.cn

Received Date: 27 December 2019
Revised Date: 29 January 2020
Accepted Date: 17 February 2020
Available Online: 19 February 2020

Figures(8)

A novel amphiphilic cationic block copolymer polylysine-b-polyphenylalanine (PLL-b-PPhe) was synthesized and self-assembled into micelles in aqueous solution, then shielded with poly(glutamic acid) (marked as PG/PLL-b-PPhe) to codeliver gene and drug for combination cancer therapy. Here, doxorubicin (DOX) was selected to be loaded into PLL-b-PPhe micelles and the drug loading efficiency was 8.0%. The drug release studies revealed that the PLL-b-PPhe micelles were pH sensitive and the released DOX could reach to 53.0%, 65.0%, 72.0% at pH 7.4, 6.8 and 5.0, respectively. In order to reduce positive charge and cytotoxicity of PLL-b-PPhe micelles, PG was used as shelding, simultaneously condensed with Bcl2 siRNA to form gene carrier system. Compared with PEI, PG/PLL-b-PPhe had excellent gene transfection efficiency, especially when the molar ratio of PLL to PPhe was 30:60 and the mixed mass ratio of PLL-b-PPhe to gene was 5:1. More importantly, DOX and Bcl2 siRNA gene codelivery system displayed remarkable cytotoxicity against B16F10 cells. Confocal laser scanning microscopy (CLSM) and flow cytometry were used to characterize endocytosis of the codelivery system, and confirmed that both DOX and Bcl2 siRNA had been endocytosed into B16F10 cells. The above results indicated that gene and drug codelivery was a promising strategy in future cancer therapy.
- Codelivery,
- Shielding,
- Doxorubicin,
- Bcl2 siRNA,
- Cancer therapy
1. [1]
  F. Bray, J. Ferlay, I. Soerjomataram, et al., CA-Cancer J. Clin. 68(2018) 394-424. doi: 10.3322/caac.21492
2. [2]
  H. Fang, Z. Guo, L. Lin, et al., J. Am. Chem. Soc. 140(2018) 11992-12000. doi: 10.1021/jacs.8b05341
3. [3]
  J. Liu, H.J. Li, Y.L. Luo, et al., ACS Nano 13(2019) 8648-8658. doi: 10.1021/acsnano.9b03472
4. [4]
  H.F. Wang, R. Ran, Y. Liu, et al., ACS Nano 12(2018) 11600-11609. doi: 10.1021/acsnano.8b06846
5. [5]
  C. Yao, J. Tian, H. Wang, et al., Chin. Chem. Lett. 28(2017) 893-899. doi: 10.1016/j.cclet.2017.01.005
6. [6]
  J. Ding, J. Chen, L. Gao, et al., Nano Today 29(2019) 100800. doi: 10.1016/j.nantod.2019.100800
7. [7]
  V. Torchilin, Adv. Drug. Deliver. Rev. 63(2011) 131-135. doi: 10.1016/j.addr.2010.03.011
8. [8]
  L. Yan, S.H. Crayton, J.P. Thawani, et al., Small 11(2015) 4870-4874. doi: 10.1002/smll.201501412
9. [9]
  H. Zheng, Y. Zhang, L. Liu, et al., J. Am. Chem. Soc. 138(2016) 962-968. doi: 10.1021/jacs.5b11720
10. [10]
  H. Meng, M. Wang, H. Liu, et al., ACS Nano 9(2015) 3540-3557. doi: 10.1021/acsnano.5b00510
11. [11]
  D. Hanahan, R.A. Weinberg, Cell 144(2011) 646-674. doi: 10.1016/j.cell.2011.02.013
12. [12]
  F.J. Sharom, J. Membrane Biol. 160(1997) 161-175. doi: 10.1007/s002329900305
13. [13]
  X. Guan, Y. Li, Z. Jiao, et al., ACS Appl. Mater. Interfaces 7(2015) 3207-3215. doi: 10.1021/am5078123
14. [14]
  K. Han, Q. Lei, H.Z. Jia, et al., Adv. Funct. Mater. 25(2015) 1248-1257. doi: 10.1002/adfm.201403190
15. [15]
  H. Tian, Z. Guo, L. Lin, et al., J. Control. Release 174(2014) 117-125. doi: 10.1016/j.jconrel.2013.11.008
16. [16]
  C.H. Ahn, S.Y. Chae, Y.H. Bae, S.W. Kim, J. Control. Release 80(2001) 273-282.
17. [17]
  J. Lina, Y. Zou, C. Wang, et al., Mater. Sci. Eng. C 44(2014) 430-439. doi: 10.1016/j.msec.2014.07.049
18. [18]
  Q. Zhu, Y. Zhou, M. Guan, et al., Biomaterials 35(2014) 5965-5976. doi: 10.1016/j.biomaterials.2014.03.088
19. [19]
  A.H. Dantzig, R.L. Shepard, J. Cao, et al., Cancer Res. 56(1996) 4171-4179.
20. [20]
  D. Decaudin, S. Geley, T. Hirsch, et al., Cancer Res. 57(1997) 62-67.
21. [21]
  R.T. Lima, L.M. Martins, J.E. Guimaraes, C. Sambade, M.H. Vasconcelos, Cancer Gene Ther. 11(2004) 309-316. doi: 10.1038/sj.cgt.7700706
22. [22]
  C.N. Xu, H.Y. Tian, Y.B. Wang, et al., Chin. Chem. Lett. 28(2017) 807-812. doi: 10.1016/j.cclet.2016.12.013
23. [23]
  F.M. Wensveen, N.L. Alves, I.A. Derks, K.A. Reedquist, E. Eldering, Apoptosis 16(2011) 708-721. doi: 10.1007/s10495-011-0599-8
24. [24]
  J.E. Chipuk, T. Moldoveanu, F. Llambi, M.J. Parsons, D.R. Green, Mol. Cell 37(2010) 299-310. doi: 10.1016/j.molcel.2010.01.025
25. [25]
  M.L. Patil, M. Zhang, T. Minko, ACS Nano 5(2001) 1877-1887.
26. [26]
  G.G. McGill, M. Horstmann, H.R. Widlund, et al., Cell 109(2002) 707-718. doi: 10.1016/S0092-8674(02)00762-6
27. [27]
  H. Tian, L. Lin, Z. Jiao, et al., J. Control. Release 172(2013) 410-418. doi: 10.1016/j.jconrel.2013.06.026
28. [28]
  C. Zheng, M. Zheng, P. Gong, et al., Biomaterials 34(2013) 3431-3438. doi: 10.1016/j.biomaterials.2013.01.053
29. [29]
  Z. Luo, P. Li, J. Deng, et al., J. Control. Release 170(2013) 259-267. doi: 10.1016/j.jconrel.2013.05.027
30. [30]
  J. Deng, N. Gao, Y. Wang, et al., Biomacromolecules 13(2012) 3795-3804. doi: 10.1021/bm3012538
31. [31]
  T. Kurosaki, T. Kitahara, S. Kawakami, et al., J. Control. Release 142(2010) 404-410. doi: 10.1016/j.jconrel.2009.11.010
32. [32]
  J. Chluba, J.C. Voegel, G. Decher, et al., Biomacromolecules 2(2001) 800-805. doi: 10.1021/bm015529i
1. [1]
  Jia Wang , Yunxiu Fan , Shilin Xu , Zhouxue Wu , Tian Hu , Yun Lu , Yue Li , Kang Xiong , Hongjun Deng , Jingrong Huang , Bo Yang , Shaozhi Fu . Self-propelled biomotors co-deliver doxorubicin liposomes and aPD-1 antibody to fight breast cancer. Chinese Chemical Letters, 2026, 37(2): 111607-. doi: 10.1016/j.cclet.2025.111607
2. [2]
  Hao Hu , Jiacheng Wang , Si Zhang , Ben Zhang , Cuinan Jiang , Hong Tian , Xunxin Gu , Yang Sheng , Zhenghuan Zhao , Meng Li , Lu Zheng , Jing Li . Hierarchical and flexible electrode with precise H₂-production for in vivo liver cancer therapy. Chinese Chemical Letters, 2025, 36(12): 110866-. doi: 10.1016/j.cclet.2025.110866
3. [3]
  Shuheng Zhang , Yuanyuan Zhang , Wanyu Wang , Yuzhu Hu , Xinchuan Chen , Bilan Wang , Xiang Gao . A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy. Chinese Chemical Letters, 2024, 35(12): 109658-. doi: 10.1016/j.cclet.2024.109658
4. [4]
  Jiangshan Xu , Weifei Zhang , Zhengwen Cai , Yong Li , Long Bai , Shaojingya Gao , Qiang Sun , Yunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620
5. [5]
  Xiangqian Cao , Chenkai Yang , Xiaodong Zhu , Mengxin Zhao , Yilin Yan , Zhengnan Huang , Jinming Cai , Jingming Zhuang , Shengzhou Li , Wei Li , Bing Shen . Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM. Chinese Chemical Letters, 2024, 35(8): 109199-. doi: 10.1016/j.cclet.2023.109199
6. [6]
  Hongyi Huang , Siyao Che , Wenjie Zhou , Yunchu Zhang , Weiling Zhuo , Xijing Yang , Songping Zheng , Jiagang Liu , Xiang Gao . Apatinib potentiates doxorubicin with cRGD-functionalized pH-sensitive micelles against glioma. Chinese Chemical Letters, 2025, 36(5): 110084-. doi: 10.1016/j.cclet.2024.110084
7. [7]
  Xin Liu , Haoran Zhu , Yi Wang , Haili Zhang , Yujie Li , Hongcheng Gao , Yi Han , Dejin Wang , Yunsheng Xia . Carbon dots-embedded hydrogel ratiometric fluorescent platform for portable determination of doxorubicin in clinical samples. Chinese Chemical Letters, 2026, 37(2): 111891-. doi: 10.1016/j.cclet.2025.111891
8. [8]
  Xiaopeng Han , Jiayin Li , Fei Li , Zhongyue Yuan , Hao Li , Lei Yang , Yan-Ming Xia , Chao Teng , Chao Qin , Lifang Yin . ROS-sensitive dihydroartemisinin prodrug amplify chemo-immunotherapy efficacy of doxorubicin by coordinating robust tumor cell immunogenic cell death and PD-L1 blockade. Chinese Chemical Letters, 2026, 37(2): 111335-. doi: 10.1016/j.cclet.2025.111335
9. [9]
  Menglin Zhang , Fanpeng Ran , Yun Zhang , Xiaoli Zhang , Zhigang Xu , Xiaoxiao Shi . Cyclodextrin-based nanotherapeutics: A promising strategy for enhanced cancer therapy. Chinese Chemical Letters, 2026, 37(1): 111232-. doi: 10.1016/j.cclet.2025.111232
10. [10]
  Zhaoyong Kang , Shen Li , Yan Li , Jingfeng Song , Yangrui Peng , Yihua Chen . Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024). Chinese Chemical Letters, 2025, 36(7): 110447-. doi: 10.1016/j.cclet.2024.110447
11. [11]
  Shengyi Gong , Guoqiang Feng . Visible light-triggered NIR ratiometric fluorescent metal-free CO-releasing molecule for self-monitoring of CO delivery and effective cancer therapy. Chinese Chemical Letters, 2025, 36(7): 110409-. doi: 10.1016/j.cclet.2024.110409
12. [12]
  Xin Li , Fei Xiong , Xudong Cao , Wei Liu , Haobo Chen , Jiayu He , Weina Zhang , Longguang Tang , Wei Huang , Xikuang Yao . CD44-targeting and ZIF-8 gated gold nanocage for programmed breast cancer therapy through Pt-induced immunogenic cell death. Chinese Chemical Letters, 2026, 37(1): 110970-. doi: 10.1016/j.cclet.2025.110970
13. [13]
  Yuanyi Zhou , Ke Ma , Jinfeng Liu , Zirun Zheng , Bo Hu , Yu Meng , Zhizhong Li , Mingshan Zhu . Is reactive oxygen species the only way for cancer inhibition over single atom nanomedicine? Autophagy regulation also works. Chinese Chemical Letters, 2024, 35(6): 109056-. doi: 10.1016/j.cclet.2023.109056
14. [14]
  Yupeng Wang , Xinxin Sun , Jianbin Shi , Zhixiao Zhang , Jin Sun , Cong Luo , Zhonggui He , Shenwu Zhang . Chain architecture-engineered artesunate nanoassemblies target LONP1 to induce oxidative damage for enhanced anti-tumor therapy. Chinese Chemical Letters, 2026, 37(1): 111609-. doi: 10.1016/j.cclet.2025.111609
15. [15]
  Ziqin Li , Kai Hao , Longwei Xiang , Huayu Tian . Cationic covalent organic framework nanocarriers integrating both efficient gene silencing and real-time gene detection. Chinese Chemical Letters, 2025, 36(4): 109943-. doi: 10.1016/j.cclet.2024.109943
16. [16]
  Yixin Sun , Keke Yu , Xiuchun Guo , Lanlan Zong , Zhonggui He , Xiaohui Pu . Three-in-one reduction and acid-ignited micelles amplify antitumor efficacy via precise synergistic delivery of paclitaxel and naringenin. Chinese Chemical Letters, 2025, 36(6): 110393-. doi: 10.1016/j.cclet.2024.110393
17. [17]
  Xuanbo Zhang , Feng Fang , Na Li , Huicong Zhang , Kaiyuan Wang , Zhiqiang Yu , Jin Sun . From reversible to irreversible: Albumin-hitchhiking gemcitabine prodrugs for enhanced antitumor efficacy and reduced toxicity. Chinese Chemical Letters, 2026, 37(2): 111452-. doi: 10.1016/j.cclet.2025.111452
18. [18]
  Ming Xu , Teng Deng , Chenzhaosha Li , Hongyang Zhao , Juan Wang , Yatao Liu , Jianan Wang , Guodong Feng , Na Li , Shujiang Ding , Kai Xi . Oxygen deficient Eu₂O₃₋_δ synchronizes the shielding and catalytic conversion of polysulfides toward high-performance lithium sulfur batteries. Chinese Chemical Letters, 2025, 36(10): 110372-. doi: 10.1016/j.cclet.2024.110372
19. [19]
  Huijiao Fu , Peiqin Liang , Qianwen Chen , Yan Wang , Guang Li , Xuzi Cai , Shengtao Wang , Kun Chen , Shengying Shi , Zhiqiang Yu , Xuefeng Wang . COX-2 blocking therapy in cisplatin chemosensitization of ovarian cancer: An allicin-based nanomedicine approach. Chinese Chemical Letters, 2024, 35(8): 109241-. doi: 10.1016/j.cclet.2023.109241
20. [20]
  Lintao Wu , Yujia Meng , Xumei Zheng , Yiqiao Bai , Chun Han , Zhijun Wang , Jie Yang , Xiaobi Jing , Yong Yao . Pillar[5]arene based prodrug as a GSH-responsive SO₂ nanogenerator for effective gas cancer therapy. Chinese Chemical Letters, 2025, 36(9): 110808-. doi: 10.1016/j.cclet.2024.110808

Get Citation

PDF

XML

Metrics

PDF Downloads(7)
Abstract views(2236)
HTML views(191)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142